Britain's Native Antigen Company introduces novel coronavirus antigens

British-based The Native Antigen Company said on Wednesday that it had introduced novel antigens to deal with the coronavirus afflicting China. "The Native Antigen Company, one of the world's leading suppliers of reagents that enable research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial introduction of its Novel Coronavirus antigens, derived from the emerging Wuhan strain," it said in a statement.

"These recombinant proteins offer scientists high-quality reagents to support ongoing infectious disease research, and the development of diagnostics and vaccines," added the company.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)